Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0A1QJ
|
|||
Former ID |
DNC001421
|
|||
Drug Name |
Tellurium
|
|||
Synonyms |
Tellurium; 13494-80-9; Telloy; Tellur; Aurum paradoxum; Tellurium element; Tellur [Polish]; Metallum problematum; Tellurium, metallic; Tellurium, elemental; Tellurium Atom; UNII-NQA0O090ZJ; Tellurium and compounds; HSDB 2532; NCI-C60117; EINECS 236-813-4; NQA0O090ZJ; teluro; Tellurium, 99+%, (trace metal basis), powder; Tellurium, 99.999%, (trace metal basis), powder; tellure; Tellurium compounds, n.o.s.; Tellurium, 99.8%, (trace metal basis), powder, -200 mesh; Tellurium powder; Tellurium compounds; ACMC-1BQVR; 52Te; EC 236-813-4
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
Te
|
|||
Canonical SMILES |
[Te]
|
|||
InChI |
1S/Te
|
|||
InChIKey |
PORWMNRCUJJQNO-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 13494-80-9
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
6233131, 7890735, 8020366, 10514260, 11600289, 15388371, 16410393, 24852275, 24855962, 24855963, 24856041, 24856140, 24868693, 24888604, 42974933, 49658636, 49854958, 50049620, 51075757, 56371253, 57365914, 77578376, 93618388, 114449275, 117682981, 118309590, 126672821, 134340529, 134340607, 134991308, 135268760, 137001630, 137171626, 137240393, 140202937, 143435218, 143472660, 143801827, 160649668, 162094955, 162271686, 162474255, 163802217, 164847921, 175266061, 176269486, 179692759, 184609360, 198988129, 204359562
|
|||
ChEBI ID |
CHEBI:30452
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Squalene monooxygenase (SQLE) | Target Info | Inhibitor | [1] |
KEGG Pathway | Steroid biosynthesis | |||
Sesquiterpenoid and triterpenoid biosynthesis | ||||
Metabolic pathways | ||||
Biosynthesis of secondary metabolites | ||||
Biosynthesis of antibiotics | ||||
Pathwhiz Pathway | Steroid Biosynthesis | |||
Reactome | Cholesterol biosynthesis | |||
Activation of gene expression by SREBF (SREBP) |
References | Top | |||
---|---|---|---|---|
REF 1 | Squalene epoxidase as hypocholesterolemic drug target revisited. Prog Lipid Res. 2003 Jan;42(1):37-50. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.